Advertisement

Topics

Rosetta Genomics Company Profile

14:41 EDT 25th September 2018 | BioPortfolio

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools. The company’s first three microRNA-based tests, miRview™ squamous, miRview™ mets and miRview™ meso, are commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab. Rosetta Genomics is the 2008 winner of the Wall Street Journal’s Technology Innovation Awards in the medical/biotech category. To learn more, please visit www.rosettagenomics.com.

Location

10 Plaut St.,
Rehovot
76706
Israel

Contact

Phone: +972 8 948 4755
Fax: +972 8 948 4766


News Articles [353 Associated News Articles listed on BioPortfolio]

Rosetta Genomics Ltd.: Rosetta Announces That Completion of Genoptix Transaction Uncertain

Rosetta Contemplates Bankruptcy Filing May 31, 2018 PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / May 29, 2018 / Rosetta Genomics Ltd. (NASDAQ: ROSG; OTC PINK: ROSGF)(the "Company") announce...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 26, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) today announced that its shareholders approved a proposed merger with a sub...

Rosetta Genomics Ltd.: Rosetta Announces Resignation of CEO

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 10, 2018 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and a...

Rosetta Genomics Ltd.: Nasdaq Hearing Panel Determined to Delist Shares of Rosetta Genomics from Nasdaq Stock Market Effective May 22, 2018

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / May 18, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) announced today that on May 18, 2018, it received a decision letter from NASD...

$9M Genoptix merger OK'd by Rosetta Genomics shareholders

Genoptix's proposed acquisition of Rosetta Genomics, valued at $9 million, received approval from Rosetta's shareholders.  -More- 

Rosetta Genomics Ltd.: Genoptix Enters into Agreement to Market and Distribute Rosetta Genomics' Testing Services Worldwide

Genoptix Will Have Exclusive Distribution Rights in the U.S. and Non-exclusive Rights in Most Geographies Outside the U.S. CARLSBAD, CA, PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / March 13...

Rosetta Genomics Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 31052018] Prices from USD $350

Rosetta Genomics Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Rosetta Genomics Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment...

Rosetta Genomics Ltd.: Rosetta Sets a New Date for Shareholder Meeting to Approve Genoptix Merger

Previously announced meeting date of April 6, 2018, for its extraordinary general meeting of shareholders, has been cancelled and rescheduled for April 17, 2018 New record date for shareholder mee...

Drugs and Medications [0 Results]

None

PubMed Articles [207 Associated PubMed Articles listed on BioPortfolio]

Systematic comparison of Amber and Rosetta energy functions for protein structure evaluation.

An accurate energy function is an essential component of biomolecular structural modeling and design. The comparison of differently derived energy functions enables analysis of the strengths and weakn...

Rosetta Protein Structure Prediction from Hydroxyl Radical Protein Footprinting Mass Spectrometry Data.

In recent years mass spectrometry-based covalent labeling techniques such as hydroxyl radical footprinting (HRF) have emerged as valuable structural biology techniques, yielding information on protein...

Recent developments of software and database in microbial genomics and functional genomics.

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

Clinical Trials [91 Associated Clinical Trials listed on BioPortfolio]

RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial

The ROSETTA-trial will evaluate the effect of acupuncture as a complementary treatment parallel to radiation therapy in oncological patients. The trial is designed as a two-armed trial. De...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

Cognitive Brain Training in Older Adults

The investigators will conduct a 8-week proof-of-concept randomized controlled trial to provide preliminary evidence of efficacy of Fit Brains (Rosetta Stone Canada) training -- a mobile c...

Companies [413 Associated Companies listed on BioPortfolio]

Rosetta Genomics

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and sta...

Rosetta Genomics Ltd.

Rosetta Genomics (NASDAQ: ROSG) is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinfo...

Rosetta Genomics, Ltd.

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and sta...

Rosetta Genomics Ltd. and Biocept, Inc.

Rosetta develops and commercializes a full range of microRNA-based and other molecular diagnostics. Rosetta’s integrative research platform combining bioinformatics and state...

Rosetta Stone Inc.

Rosetta Stone Inc. is changing the way the world learns languages. Rosetta Stone provides interactive solutions that are acclaimed for the speed and power to unlock the natural la...

More Information about "Rosetta Genomics" on BioPortfolio

We have published hundreds of Rosetta Genomics news stories on BioPortfolio along with dozens of Rosetta Genomics Clinical Trials and PubMed Articles about Rosetta Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rosetta Genomics Companies in our database. You can also find out about relevant Rosetta Genomics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...


Corporate Database Quicklinks



Searches Linking to this Company Record